TY - CHAP M1 - Book, Section TI - Leprosy A1 - Yotsu, Rie Roselyne A1 - Ishii, Norihisa A1 - Rajagopalan, Shobita A2 - Kelly, A. Paul A2 - Taylor, Susan C. A2 - Lim, Henry W. A2 - Serrano, Ana Maria Anido PY - 2016 T2 - Taylor and Kelly's Dermatology for Skin of Color, 2e AB - KEY POINTSLeprosy is a mycobacterial infection that affects the skin and the peripheral nerves.There are over 200,000 new cases of leprosy diagnosed every year around the world.Various skin symptoms are associated with the disease depending on the immune reaction of the host (patient), including hypopigmentation, erythema, and nodules.Multidrug therapy, which is a combination of dapsone, rifampicin, and clofazimine, effectively cures the disease and is recommended as the first-line therapy by the World Health Organization.Deformities as a consequence of the disease lead to social discrimination and stigma and, hence, the need for early detection and treatment. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - dermatology.mhmedical.com/content.aspx?aid=1161548632 ER -